Fluor Corporation - FLR STOCK NEWS

Fluor Corporation (NYSE: FLR) will host a conference call on May 5, 2023, at 8:30 a.m. Eastern to discuss its first-quarter results for the period ending March 31, 2023. Participants can access the call via telephone or listen to a live webcast on the company's investor relations website, investor.fluor.com. A replay of the call will be available for 30 days following the event. In 2022, Fluor reported revenue of $13.7 billion and is recognized among the Fortune 500 companies, ranked 259. The company has a strong global presence, providing solutions for engineering, procurement, and construction over its 110-year history.

Fluor Corporation (NYSE: FLR) has signed a license agreement with Federated Co-Operatives Limited (FCL) to implement its Econamine FG Plus^SM carbon capture technology at FCL's Co-op Renewable Diesel Complex in Regina, Saskatchewan, Canada. This project is part of FCL's $2 billion investment aimed at integrating agricultural and energy solutions, with the facility expected to be operational by 2027. Fluor will also deliver a process design package to help FCL achieve a 40% reduction in greenhouse gas emissions by 2030. This agreement highlights Fluor's commitment to supporting decarbonization efforts, reflecting increasing activity in carbon capture technology.

Fluor Corporation (NYSE: FLR) has entered into a memorandum of understanding (MOU) with Longview Fusion Energy Systems, Inc. to partner in the design and planning of laser fusion energy plants. These plants are expected to generate carbon-free energy, with capacities ranging from 1,000 to 1,600 MW, sufficient to power small cities or provide industrial process heat. Fluor aims to leverage its extensive experience in building large-scale facilities to support Longview's fusion technology, which is based on a recent breakthrough at the National Ignition Facility. This partnership highlights Fluor's commitment to sustainable energy solutions and aims to meet the increasing global demand for clean energy.

Fluor Corporation (NYSE: FLR) has been awarded a significant contract by the U.S. Department of Energy (DOE) for the Hanford Integrated Tank Disposition, valued at up to $45 billion over a period of 10 years. This project involves environmental management operations at the Hanford Site in Washington state, which is critical for cleaning up radioactive waste from past nuclear fuel production. Fluor will operate the Hanford tank farm facilities and manage operations at the Waste Treatment and Immobilization Plant, among other responsibilities. This marks a continuation of Fluor's commitment to the Tri-Cities community, where it has been active for over 25 years.

Fluor Corporation (NYSE: FLR) has announced the successful sale of its AMECO South America business to STRACON Group, finalizing its AMECO divestiture strategy. This strategic move, which also included previous divestitures in regions such as Africa, North America, and the Caribbean, aims to enable Fluor to concentrate on its core operations and capital priorities. AMECO South America specializes in providing mobile equipment services for the mining sector. In 2022, Fluor reported revenues of $13.7 billion, continuing its focus on safe, efficient project execution.

Fluor Corporation (NYSE: FLR) revealed significant growth in its financial results for the year ended December 31, 2022. Full-year new awards doubled to $19.8 billion, with an ending backlog that increased by 25% to $26 billion. The company's revenue reached $13.7 billion, with net income from continuing operations at $145 million or $0.73 per diluted share. Adjusted earnings per diluted share were $0.82. Fluor's cash and marketable securities stood at $2.6 billion, while outstanding debt was less than $1 billion, reflecting a strengthened capital structure.

Fluor Corporation (NYSE: FLR) has been selected by Agilent Technologies to expand its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. The project, valued at $725 million, includes engineering and procurement services aimed at optimizing cost and construction speed. Fluor's new 275,000 square-foot facility will double Agilent's manufacturing capability and is expected to support the synthesis of critical nucleic acids for various diseases. Construction is currently underway, with completion projected by 2026.